TRPV4 and neuromuscular disease: Dominant mutations in ARHGEF10 are associated with forms of human neuromuscular disease (47, 48, 49, 50), as well as a form of neuromuscular disease in dogs that involves vocal fold paresis (51), a characteristic feature of TRPV4-mediated disease (11, 17, 20).